Related Experiment Video

Updated: Aug 20, 2026

A Miniaturized Glycan Microarray Assay for Assessing Avidity and Specificity of Influenza A Virus Hemagglutinins
10:32

A Miniaturized Glycan Microarray Assay for Assessing Avidity and Specificity of Influenza A Virus Hemagglutinins

Published on: May 29, 2016

Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons

Carolina Scagnolari1, Elisa Vicenzi, Francesca Bellomi

  • 1Department of Exerimental Medicine and Pathology--Virology section, University La Sapienza, Rome, Italy.

Antiviral Therapy
|January 18, 2005
PubMed

Insights

Interferon-beta shows moderate effectiveness against SARS-CoV replication in Vero cells, potentially acting synergistically with interferon-gamma. This antiviral activity appears independent of MxA protein expression.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Urgent need for effective antiviral agents against SARS-CoV.
  • Interferons (IFNs) are a class of cytokines with known antiviral properties.
  • Previous studies have shown variable responses of different viruses to IFNs.

Purpose of the Study:

  • To compare the antiviral effects of different interferons (IFNs) on SARS-CoV replication.
  • To investigate the potential synergistic effects of IFN combinations against SARS-CoV.
  • To determine the role of MxA protein in IFN-mediated antiviral activity against SARS-CoV.

Main Methods:

  • SARS-CoV replication was studied in Vero cell lines.
  • Different types of interferons (IFN-alpha, IFN-beta, IFN-gamma) were applied.
  • Cell cultures were simultaneously incubated with combinations of IFNs.
  • Expression of the IFN-induced MxA protein was analyzed.

Main Results:

  • SARS-CoV demonstrated moderate sensitivity to IFN-beta.
  • SARS-CoV showed weak sensitivity to IFN-alpha and IFN-gamma.
  • IFN-beta and IFN-gamma exhibited potential synergistic effects against SARS-CoV.
  • MxA protein was detected in IFN-treated cells, but its expression was independent of antiviral activity.

Conclusions:

  • IFN-beta is a promising candidate for SARS-CoV treatment, with potential synergistic benefits from IFN-gamma.
  • The antiviral mechanism of IFNs against SARS-CoV in this model is not solely dependent on MxA protein induction.
  • Further research into IFN-based therapies for SARS-CoV is warranted.

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Rescue of Recombinant Newcastle Disease Virus from cDNA10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Related Concept Videos

Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.